Cargando...
Modeling HIV/AIDS Drug Price Determinants in Brazil: Is Generic Competition a Myth?
BACKGROUND: Brazil became the first developing country to guarantee free and universal access to HIV/AIDS treatment, with antiretroviral drugs (ARVs) being delivered to nearly 190,000 patients. The analysis of ARV price evolution and market dynamics in Brazil can help anticipate issues soon to affli...
Gardado en:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Public Library of Science
2011
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3156239/ https://ncbi.nlm.nih.gov/pubmed/21858138 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0023478 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|